Epigenetic Targeting in Myeloid Malignancies.
This chapter aims to provide a detailed and comprehensive overview of epigenetic drugs currently available in both preclinical and clinical testing, with a particular focus on agents directed against histone deacetylases, DNA methyltransferases, DNMTs, histone methyltransferases, histone demethylases, bromodomain and e...